Improve selfmanagement for nonmotor symptoms
- Trial ID
- NCT07038486
- Official Title
- The Impact of a Digital System on the Monitoring and Self-management of Non-motor Symptoms in People With Parkinson's
- Goal
- Improve selfmanagement for nonmotor symptoms
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Newcastle University
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- Parkinson Disease
- Interventions
- NMS Assist
Plain-Language Summary
The goal is to help people with Parkinson's better monitor and manage non-motor symptoms, like mood, sleep, and autonomic problems, so these often-hidden issues cause less daily disruption. The approach uses a smartphone-based system called NMS Assist that lets users log symptoms, track patterns over time, and receive tailored prompts and summaries to support self-management and communication with caregivers or clinicians. The trial is looking for adults 18 and over with a clinical Parkinson's diagnosis who are ambulant, not living in residential care, fluent in English, and have access to a compatible smartphone. People with significant cognitive impairment or Parkinson's disease dementia, secondary parkinsonism, recent involvement in the system's development, or other serious health issues that would make participation unsafe are excluded, and caregivers of participating patients may also join.
Locations
- Newcastle University, Newcastle upon Tyne, Tyne and Wear, United Kingdom
Frequently Asked Questions
- What is this trial testing?
- This trial is studying NMS Assist. The goal is to help people with Parkinson's better monitor and manage non-motor symptoms, like mood, sleep, and autonomic problems, so these often-hidden issues cause less daily disruption. The approach uses a smartphone-based system called NMS Assist that lets users log symptoms, track patterns over time, and receive tailored prompts and summaries to support self-management and communication with caregivers or clinicians. The trial is looking for adults 18 and over with a clinical Parkinson's diagnosis who are ambulant, not living in residential care, fluent in English, and have access to a compatible smartphone. People with significant cognitive impairment or Parkinson's disease dementia, secondary parkinsonism, recent involvement in the system's development, or other serious health issues that would make participation unsafe are excluded, and caregivers of participating patients may also join.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 1 month.